6.430USD-4.03%Mkt Cap: 81.78M USDP/E: —Last update: 2026-05-26
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, w…
Industry Peers
Packaged FoodsIndicators:|
Key Statistics
Company
Market Cap81.78M USD
Enterprise Value103.13M USD
Revenue (TTM)134.00K USD
Gross Profit157.00K USD
Net Income (TTM)-26.17M USD
Revenue/Share0.0130 USD
Last Price6.430 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees76
CountryUS
SectorConsumer Defensive
IndustryPackaged Foods
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.77
PEG—
EV/EBITDA-5.26
EV/Revenue769.62
P/S649.40
P/B-4.26
EPS (TTM)-3.25
EPS (Forward)-1.43
52W Range
2.28037% of range13.50
52W High13.50 USD
52W Low2.280 USD
Profitability
Gross Margin78.50%
Oper. Margin-13740.00%
EBITDA Margin0.00%
Profit Margin-13086.50%
ROE148.78%
ROA-144.35%
Growth
Revenue Growth-81.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.55M USD
CapEx (TTM)39.00K USD
FCF Margin-8165.02%
FCF Yield-13.38%
Net Debt16.11M USD
Net Debt/EBITDA-0.82
Balance Sheet
Debt/Equity-1.23
Current Ratio1.94
Quick Ratio0.88
Book Value/Sh-1.5970 USD
Cash/Share0.4650 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJul 11, 2024
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)30.67 USD
Target Range20.00 USD – 50.00 USD
# Analysts6
Ownership
Shares Out.12.78M
Float10.12M
Insiders24.56%
Institutions22.43%
Short Interest
Short Ratio10.4d
Short % Float10.23%
Short % Out.7.43%
Shares Short875.03K
Short (prev mo.)972.73K
Technical
SMA 506.189 (+3.9%)
SMA 2006.431 (-0.0%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)928.09K
Avg Vol (10d)213.63K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—